Exact Mass: 440.2324
Exact Mass Matches: 440.2324
Found 500 metabolites which its exact mass value is equals to given mass value 440.2324
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tirofiban
Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
4-(5-Chloro-3-isopropyl-1H-pyrazol-4-yl)-N-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine
3-[2-[[(1S,2R,3S)-3-[4-(Pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid
Nemiralisib
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C78273 - Agent Affecting Respiratory System
5,7-Dihydroxy-4-methoxy-8-C-prenyl-3-(3-hydroxy-3-methylbutyl)flavanone
Scoparic acid A
A diterpenoid isolated from Scoparia dulcis and has been shown to exhibit inhibitory activity against beta-glucuronidase from bovine liver.
3-Geranyl-3,4,2,4-tetrahydroxy-6-methoxydihydrochalcone
3,2,4,6-Tetrahydroxy-4-methoxy-3,5-diprenyldihydrochalcone
linalool-beta-D-glucopyranoside-2O-acetate,6O-tiglate
1-[(2,2-Dimethyl-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran)-6-yl]-3-[3-hydroxy-4-methoxy-5-(3-methyl-2-butenyl)phenyl]-1-propanone
2,6-diheptyl-6-hydroxy-7-methoxy-dibenzofuran-3,4-dione|fordianaquinone A
cis-1-(2,4,5-trimethoxy-E-styryl)-2-(2,4,5-trimethoxy-Z-styryl)cyclobutane|trans-1-(2,4,5-trimethoxy-E-styryl)-2-(2,4,5-trimethoxy-Z-styryl)cyclobutane
methyl-[O2,O4-dimethyl-O6-(tetra-O-methyl-beta-D-galactopyranosyl)-xi-D-galactopyranoside]|Methyl-[O2,O4-dimethyl-O6-(tetra-O-methyl-beta-D-galactopyranosyl)-xi-D-galactopyranosid]
(3S,4R)-4-([(1S,4aR,6S,8aS)-decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylidenenaphthalen-1-yl]-methoxy)-5-methoxy-3-(methoxycarbonyl)-5-oxopentanoic acid|cryptoporic acid J
(9R,9aR)-9-hydroxy-9a-methyl-3-octanoyl-9-(2-oxopropyl)-6-((E)-prop-1-enyl)-9,9a-dihydro-2H-furo[3,2-g]isochromen-2-one|monaphilol C
9-hydroxy-1-methoxy-8-(3-hydroxy-3-methylbutyl)-6,6-dimethyl-4,5-dihydro-[6H]-pyrano[2,3:3,2]-pterocarpan|glycycarpan
(22R,25R)-23alpha-hydroxy-1,4-spirostadien-3,26-dione|indioside L
6-hydroxy-8-(2-hydroxy-4-methoxy-6-pentylphenoxy)-3-pentylisochromen-1-one
2(S)-5,7,4-trihydroxy-6-methyl-3-[7-hydroxy-3,7-dimethyl-2(E)-octenyl]flavanone|hirtellanine G
6-Me ether-3-(3,4-Dihydroxyphenyl)-1-[3-(3,7-dimethyl-2,6-octadienyl)-2,4,6-trihydroxyphenyl]-1-propanone
8-[(5-carboxy-2,9-epoxy)benzyl]-2,5-dihydroxy-1,1,4a,7,8-pentamethyl-1,2,3,4,4a,6,7,8,9,10,10a-dodecahydrophenanthrene
3-Ketone-(3alpha,5alpha,9alpha,10beta)-7-O-(3-Hydroxy-7-drimen-11-yl)isofraxidin
rel-(3aR,5aR,6S,9S,10aR)-2,3,3a,4,5,5a,6,9,10,10a-decahydro-8-(hydroxymethyl)-1-(2-hydroxy-1-methylethyl)-3a,5a-dimethylcyclohept[e]indene-6,9-diol|scabronine H
(1S,4aS,8aR)-7-[(decahydro-5,5,8a-trimethyl-2-methylene-6-oxo-1-naphthalenyl)methoxy]-6,8-dimethoxy-2H-1-benzopyran-2-one
7-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-4-(1-hydroxypropyl)-8-(1-oxobutyl)-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one|kayeassamin I
C27H28N4O2_(3S,6S)-3-(1H-Indol-3-ylmethyl)-6-{[2-(2-methyl-3-buten-2-yl)-1H-indol-3-yl]methyl}-2,5-piperazinedione
C19H36O11_beta-D-Glucopyranoside, 3-ethyl-4-hydroxy-4-methylpentyl 6-O-[(2S,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]
Ala His Ile Thr
Ala His Leu Thr
Ala His Thr Ile
Ala His Thr Leu
Ala Ile His Thr
Ala Ile Thr His
Ala Leu His Thr
Ala Leu Thr His
Ala Thr His Ile
Ala Thr His Leu
Ala Thr Ile His
Ala Thr Leu His
Asp Ile Pro Pro
Asp Leu Pro Pro
Asp Pro Ile Pro
Asp Pro Leu Pro
Asp Pro Pro Ile
Asp Pro Pro Leu
Glu Pro Pro Val
Glu Pro Val Pro
Glu Val Pro Pro
His Ala Ile Thr
His Ala Leu Thr
His Ala Thr Ile
His Ala Thr Leu
His Ile Ala Thr
His Ile Thr Ala
His Leu Ala Thr
His Leu Thr Ala
His Ser Val Val
His Thr Ala Ile
His Thr Ala Leu
His Thr Ile Ala
His Thr Leu Ala
His Val Ser Val
His Val Val Ser
Ile Ala His Thr
Ile Ala Thr His
Ile Asp Pro Pro
Ile His Ala Thr
Ile His Thr Ala
Ile Pro Asp Pro
Ile Pro Pro Asp
Ile Thr Ala His
Ile Thr His Ala
Leu Ala His Thr
Leu Ala Thr His
Leu Asp Pro Pro
Leu His Ala Thr
Leu His Thr Ala
Leu Pro Asp Pro
Leu Pro Pro Asp
Leu Thr Ala His
Leu Thr His Ala
Met Pro Pro Pro
Pro Asp Ile Pro
Pro Asp Leu Pro
Pro Asp Pro Ile
Pro Asp Pro Leu
Pro Glu Pro Val
Pro Glu Val Pro
Pro Ile Asp Pro
Pro Ile Pro Asp
Pro Leu Asp Pro
Pro Leu Pro Asp
Pro Met Pro Pro
Pro Pro Asp Ile
Pro Pro Asp Leu
Pro Pro Glu Val
Pro Pro Ile Asp
Pro Pro Leu Asp
Pro Pro Met Pro
Pro Pro Pro Met
Pro Pro Val Glu
Pro Val Glu Pro
Pro Val Pro Glu
Ser His Val Val
Ser Val His Val
Ser Val Val His
Thr Ala His Ile
Thr Ala His Leu
Thr Ala Ile His
Thr Ala Leu His
Thr His Ala Ile
Thr His Ala Leu
Thr His Ile Ala
Thr His Leu Ala
Thr Ile Ala His
Thr Ile His Ala
Thr Leu Ala His
Thr Leu His Ala
Val Glu Pro Pro
Val His Ser Val
Val His Val Ser
Val Pro Glu Pro
Val Pro Pro Glu
Val Ser His Val
Val Ser Val His
Val Val His Ser
Val Val Ser His
1-(2-(DI-TERT-BUTYLPHOSPHINO)PHENYL)-3,5-DIPHENYL-1H-PYRAZOLE
Ifetroban
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
2-Pyrrolidinecarboxamide, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-, (2S,4R)
Benzyl 7-(diphenylmethyl)-6-oxo-1,7-diazaspiro[4.4]nonane-1-carbo xylate
BIX 02189
BIX02189 is a potent and selective MEK5 inhibitor with an IC50 of 1.5 nM. BIX02189 also inhibits ERK5 catalytic activity with an IC50 of 59 nM.
Trans-1-[4-(4-heptylcyclohexyl)phenoxy]-2,4-dinitro benzene
1-N,4-N-bis(4-methylphenyl)-1-N,4-N-diphenylbenzene-1,4-diamine
Flumedroxone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Glycycarpan
A member of the class of pterocarpan that is a cis-pterocarpan substituted by a hydroxy group at position 9, a 3-hydroxy-3-methylbutyl group at position 8, a methoxy group at position 1 and a dimethylpyran ring fused across positions 2 and 3. It has been isolated from Glycyrrhiza uralensis.
5-[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethoxy]-2-[(3-methylphenyl)methyl]-3,4-dihydroisoquinolin-1-one
Methyl-[4-(4-piperidine-1-ylmethyl-phenyl)-cyclohexyl]-carbaminic acid-(4-chlorophenyl)-ester
Nemiralisib
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C78273 - Agent Affecting Respiratory System
16-[(2R)-1-hydroxy-3-phosphonooxypropan-2-yl]oxy-16-oxohexadecanoic acid
16-[(2R)-2-hydroxy-3-phosphonooxypropoxy]-16-oxohexadecanoic acid
methyl (1R,9S,10S,11S)-12-(cyclopentylmethyl)-5-(2-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
methyl (1R,9S,10S,11S)-12-(cyclohexanecarbonyl)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
3-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
(1S,9R,10R,11R)-12-(cyclohexylmethyl)-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(1R,9S,10S,11S)-12-(cyclohexylmethyl)-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
1-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
methyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
1-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
methyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl (1S,9R,10R,11R)-12-(cyclopentylmethyl)-5-(2-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
methyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
1-[2,4-Dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-hydroxy-3-[4-hydroxy-3-methoxy-5-(3-methylbut-2-enyl)phenyl]propan-1-one
2,3-dihydroxypropyl [2-hydroxy-3-[(Z)-tetradec-9-enoxy]propyl] hydrogen phosphate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tridec-9-enoate
2-[(2-Hexanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Acetyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(2-octanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[(3-Butanoyloxy-2-heptanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
Tirofiban
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
7-deacetylgedunin
A limonoid that is the 7-deacetyl derivative of gedunin. It has been isolated from Azadirachta indica.
(6s,8as,10s)-10-hydroxy-6,9,9,12b-tetramethyl-2-[(4e)-3-oxohex-4-en-2-yl]-5,6,7,8,8a,10,11,12-octahydro-oxatetraphene-1,4-dione
3-(3,4-dihydroxyphenyl)-1-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-6-methoxyphenyl}propan-1-one
1-(furan-3-yl)-4,6-dihydroxy-3b,9a,11a-trimethyl-9-oxo-1h,2h,4h,5h,5ah,6h,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate
(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-17'-ene-10',16',19'-trione
(2-hydroxy-1,4a-dimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-1-yl)methyl acetate
6-butanoyl-5-hydroxy-10-(1-hydroxypropyl)-2-methyl-2-(4-methylpent-3-en-1-yl)pyrano[2,3-h]chromen-8-one
7-(furan-3-yl)-19-hydroxy-1,8,12,16,16-pentamethyl-3,6-dioxapentacyclo[9.8.0.0²,⁴.0²,⁸.0¹²,¹⁷]nonadec-13-ene-5,15-dione
(4e)-6-(2,5-dihydroxy-3-methylphenyl)-1-[(1r,6r,7s)-2,4-dihydroxy-6,7,9,9-tetramethylbicyclo[4.2.1]nona-2,4-dien-7-yl]-4-methylhex-4-en-2-one
(2z)-2-[(2r,5z,9z)-13-(furan-3-yl)-2,6,10-trimethyltrideca-5,9-dien-1-ylidene]-4-methyl-5-oxofuran-3-yl acetate
(2r)-2-[(1r,4as,7s,7ar)-4,7-dimethyl-3-(3-methylbutanoyl)-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]-4-methyl-3-oxo-1-benzofuran-2-yl acetate
methyl (1r,9r,15r,16s,18r,21r)-2-acetyl-4,15-dimethoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
(2s)-2-{4-[(3,6-dimethylhept-2-en-1-yl)oxy]-3-methoxyphenyl}-5-hydroxy-7-methoxy-2,3-dihydro-1-benzopyran-4-one
8-hydroxy-3,7,11-trimethyl-1-[(2-oxochromen-7-yl)oxy]dodeca-2,6,10-trien-5-yl acetate
1-[(1r,6s,7r)-2,4-dihydroxy-6,7,9,9-tetramethylbicyclo[4.2.1]nona-2,4-dien-7-yl]-3-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]propan-2-one
2-[13-(furan-3-yl)-2,6,10-trimethyltrideca-5,10-dien-1-ylidene]-4-methyl-5-oxofuran-3-yl acetate
3-(1h-indol-3-ylmethyl)-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol
[(1r,2r,4ar,5r,8as)-2-hydroxy-1,4a-dimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-1-yl]methyl acetate
methyl 2-[13-(furan-3-yl)-2-hydroxy-4,8,10,12-tetramethyl-7-oxo-16-oxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-4,11-dien-9-yl]acetate
(1r,2r,8r,9r,11r,12r,14r,16s,17s)-16-(furan-3-yl)-9-hydroxy-2,7,7,11,17-pentamethyl-6,13-dioxapentacyclo[9.8.0.0²,⁸.0¹²,¹⁴.0¹²,¹⁷]nonadec-3-ene-5,10-dione
(5r,6e,8r,10e)-8-hydroxy-2,6,10-trimethyl-12-[(2-oxochromen-7-yl)oxy]dodeca-2,6,10-trien-5-yl acetate
(4e)-6-(2,5-dihydroxy-3-methylphenyl)-1-[(1s,6r,7r)-2,4-dihydroxy-6,7,9,9-tetramethylbicyclo[4.2.1]nona-2,4-dien-7-yl]-4-methylhex-4-en-2-one
[(3as,5as,6r,9s,10as)-6,9-dihydroxy-1-[(2r)-1-hydroxypropan-2-yl]-3a,5a-dimethyl-2h,3h,4h,5h,6h,9h,10h,10ah-cyclohepta[e]inden-8-yl]methyl benzoate
(8e,11s,13s,16s)-22-hydroxy-16-(2-hydroxypropan-2-yl)-4,8,13-trimethyl-12,17-dioxatetracyclo[17.3.1.0³,⁷.0¹¹,¹³]tricosa-1(23),3,8,19,21-pentaen-18-one
2-[(2e,6e)-10-[(3z,6r)-6-(2-hydroxypropan-2-yl)-2-oxooxan-3-ylidene]-3,7-dimethyldeca-2,6-dien-1-yl]-6-methylcyclohexa-2,5-diene-1,4-dione
(2s,4's,4'ar,4'bs,8'ar,10'ar)-4'-hydroxy-2',4'b,6,7,8',8',10'a-heptamethyl-4'a,5',6',8'a,9',10'-hexahydro-3h,4'h-spiro[furo[3,2-c]pyran-2,1'-phenanthrene]-4,7'-dione
(1s,3s,4s,6r,8s,9s,10s,11r,14r,15r,17r)-3,4,10,15-tetrahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-17-yl 2-hydroxypropanoate
(16e)-6-(2-amino-4-methylpentanoyl)-14-hydroxy-2-oxa-6,9,15-triazatetracyclo[16.2.2.0³,⁷.0⁹,¹³]docosa-1(20),14,16,18,21-pentaen-8-one
3-[3,7-dimethyl-11-(4-methylpent-3-en-1-yl)-12-oxododeca-2,6,10-trien-1-yl]-4,5-dihydroxybenzoic acid
1-[(2s)-4,6-dihydroxy-2-(2-hydroxypropan-2-yl)-5-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzofuran-7-yl]-3-(4-methoxyphenyl)propan-1-one
1,2,4-trimethoxy-5-[(1z)-2-[(1s,2r)-2-[(1e)-2-(2,4,5-trimethoxyphenyl)ethenyl]cyclobutyl]ethenyl]benzene
7-[8-(2-methoxy-3,5,6-trimethyl-2,6-dihydropyran-3-yl)nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
3-[(2e,6e,10e)-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)-12-oxododeca-2,6,10-trien-1-yl]-4,5-dihydroxybenzoic acid
(2z)-2-[(2r,6e,10e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-6,10-dien-1-ylidene]-4-methyl-5-oxofuran-3-yl acetate
1,2-bis(2,4,5-trimethoxy-z-styryl)cyclobutane
{"Ingredient_id": "HBIN000763","Ingredient_name": "1,2-bis(2,4,5-trimethoxy-z-styryl)cyclobutane","Alias": "NA","Ingredient_formula": "C26H32O6","Ingredient_Smile": "COC1=CC(=C(C=C1C=CC2CCC2C=CC3=CC(=C(C=C3OC)OC)OC)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21916","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
asebotoxin iii
{"Ingredient_id": "HBIN017048","Ingredient_name": "asebotoxin iii","Alias": "NA","Ingredient_formula": "C23H36O8","Ingredient_Smile": "CC(C(=O)OC1C2CCC3C1(CC(C4(C(C3(C)O)C5C(C4(C)C)O5)O)O)CC2(C)O)O","Ingredient_weight": "440.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1850","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137117256","DrugBank_id": "NA"}